HempFusion Corporate Media Kit

28 W W W . H E M P F U S I O N . C O M | H E M P F U S I O N ® P R E S E N T A T I O N GROUNDBREAKING RESEARCH ON CBD AND HUMAN SAFETY P A R T N E R S H I P S HempFusion is one of ten select CBD companies participating in and sponsoring a ground-breaking study with ValidCare on CBD and human safety which is expected to complete by the end of October (1) What is ValidCare? ValidCare provides clinical research and consumer intelligence solutions for CPG and life sciences industries This scientific study is designed to address previous Food and Drug Administration's ("FDA") questions about CBD products. ValidCare, HempFusion and select other companies will be conducting a human trial and study to determine if daily use of full-spectrum hemp-derived CBD or CBD isolate has any impact on the human liver Why does this matter? 1. Beyond advancing the science surrounding CBD, major CPG brands are awaiting the results, which can lead to industry-leading partnerships 2. “We believe this real-world evidence is important to the FDA and could be used to guide policy moving forward,” Patrick McCarthy, CEO of ValidCare 3. This study has the potential to attract some of the largest big-box retailers and FDM companies in the United States "We are excited that HempFusion is one of the select companies participating in this study as they have demonstrated leadership in regulatory compliance and concern for consumer safety." — PATR ICK MCCARTHY, CEO OF VAL IDCARE R E S E A R C H & D E V E L O P M E N T (1) ValidCare LLC has confirmed ten select participants